Skip to main content
. 2022 Nov 17;2022(11):CD014963. doi: 10.1002/14651858.CD014963.pub2

9.1. Analysis.

9.1

Comparison 9: High‐dose dexamethasone (12 mg/d or higher) versus low‐dose dexamethasone (6 to 8 mg/d) for hospitalised individuals with a confirmed diagnosis of symptomatic COVID‐19, Outcome 1: All‐cause mortality up to 30 days